Article/items published online ahead of print or online only
Latest Entry: Measuring Progress in Mesothelioma Treatment
9/18/2018 Q&A With Clive Zent, MD, on Chronic Lymphocytic Leukemia
FDA ACTIONS & UPDATES
The latest approvals, designations, and new indications from the U.S. Food and Drug Administration for oncology drugs.
Latest Entry: Ivosidenib FDA-Approved for Adult Patients With R/R Acute Myeloid Leukemia & an IDH1 Mutation
MUSINGS OF A CANCER DOCTORBy George W. Sledge, Jr., MDObservations, ponderings, and views.
Latest Entry: Oncology Times at 40: Looking Back
ONCOLOGISTS' GUIDE TO GENOMICSThe latest trends in genomics and molecular diagnostics for oncology.
Latest Entry: New Genetic Markers for Prostate Cancer
VIEW FROM THE OTHER SIDE OF THE STETHOSCOPEBy Wendy S. Harpham, MD, FACPA unique perspective on oncology practices.
Latest Entry: To Try or Not to Try
3 QUESTIONS ON...Answers straight from the experts on the latest news and topics in oncology.
Latest Entry: Heart Problems in Survivors of Childhood Cancer
August 25th, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 16
August 25th, 2016
July 10th, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 13
February 10th, 2013 - Volume 35 - SABCS Meeting Reporter Special Edition Supplement
All the latest news,
plus a look back at
OT's comprehensive coverage on...
And for more topics in oncology, browse our full list of
Exclusive interviews and perspectives from our iPad archives
Most Recently Added: "How Health IT is Changing Oncology"—Andrew Zelenetz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets...